解读心力衰竭中QLQX囊的分子机制:一个多omics视角
Jiameng Hao1, Mingye Wang2, Qiulan Wu3
1China Science and Technology Development Center for Chinese Medicine, Beijing, China.
概括
奇利辛 (QLQX) 囊通过增强心脏功能来改善心力衰竭与保存的喷射分数 (HFpEF). 这种传统中医药调节多个分子通路,支持其治疗潜力.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 心脏衰竭与保存的喷射分数 (HFpEF) 在治疗中提出了复杂的挑战.
- 了解HFpEF背后的分子机制对于开发有效疗法至关重要.
研究的目的:
- 在HFpEF的老鼠模型中研究Qiliqiangxin (QLQX) 囊的治疗机制.
- 阐明QLQX如何影响HFpEF中的心脏功能和分子通路.
主要方法:
- 在老鼠中通过切除术,DOCA和高盐饮食诱导HFpEF.
- 使用心声学评估心脏功能;通过网络药理学和多态学 (转录组学,蛋白质组学,代谢组学) 探索分子机制.
- 定量RT-PCR验证了关键心脏标志物的表达.
主要成果:
- 在HFpEF大鼠中,QLQX显著改善了喷射分数和透气功能.
- 网络药理学确定了QLQX和HFpEF之间的38个重叠目标,突出了cGMP-PKG,上腺和信号通路.
- 多omics分析显示,QLQX逆转了与HFpEF相关的炎症,能量代谢和脂质代谢的变化,主要通过cGMP-PKG通路.
结论:
- QLQX通过调节基因表达,蛋白质功能和代谢途径,对HFpEF表现出多方面的治疗作用.
- cGMP-PKG信号通路是QLQX在HFpEF中的有益作用的关键调解者.
- QLQX是HFpEF的一种有前途的治疗药物,可以改善心脏功能并逆转病态变化.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
01:26Heart Failure Drugs: Inotropic Agents
547
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
547
01:22Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352